In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Update on heart failure and diabetes: what is the potential role of semaglutide and the combination of GIP-GLP1 receptor agonists in the management of HF? - Video

07 Jan 2025

In this video, Professor Marx (RWTH University Hospital Aachen, Aachen, Germany) joins Associate Professor Christodorescu (University of Medicine and Pharmacy Victor Babes, Timişoara, Romania) to discuss updates on heart failure and diabetes: what is the potential role of semaglutide and the combination of GIP-GLP1 receptor agonists in the management of HF?

The content of this article reflects the personal opinion of the author/s and is not necessarily the official position of the European Society of Cardiology.
About the ESC
Press and Media
Information
Follow us

         

 Need help?

 Help centre
 Contact us

© 2024 European Society of Cardiology. All rights reserved.